Fulgent Genetics Inc reports results for the quarter ended in June - Earnings Summary

Fulgent Genetics

09/08/2021 23:46

* Fulgent Genetics Inc  FLGT.OQ  reported quarterly adjusted
earnings of $2.47​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was
for earnings of $2.76 per share.
* Revenue rose 789.8% to $153.62 million from a year ago; 
analysts expected $197.34 million. 
* Fulgent Genetics Inc's reported EPS for the quarter was
$2.59​.
* The mean earnings estimate of analysts had risen by about 1%
in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Fulgent Genetics Inc shares had risen by 14.7% this
quarter and gained 103.0% so far this year.
* The company reported quarterly net income of $79.81 million.
* Wall Street's median 12-month price target for Fulgent
Genetics Inc is $118.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated August 9 at 10:45 p.m.  ​All
figures in US dollars unless otherwise stated